Robert E Denroche

15PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 23, 2022
Widespread hypertranscription in aggressive human cancers.

Matthew Zatzman, Fabio Fuligni, Ryan Ripsman

|Oct 12, 2022
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.

Sheron Perera, Gun Ho Jang, Yifan Wang

|Oct 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.

James T Topham, Joanna M Karasinska, Michael K C Lee

|Sep 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?

Erica S Tsang, James T Topham, Joanna M Karasinska

|Aug 21, 2020
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer.

Yifan Wang, Jin Yong Patrick Park, Alain Pacis

Pageof 3